NCT00210925View on ClinicalTrials.gov

An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

371

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2006

Conditions
Alcoholism
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210925 - An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence | Biotech Hunter | Biotech Hunter